| Literature DB >> 29231762 |
Constantin Bălăeţ1,2, Bogdan Ioan Coculescu1,3,4, Maria Bălăeţ5, Gheorghe Manole3,6, Gabi Valeriu Dincă3.
Abstract
For the medical practice, our manuscript acts as a signal, despite only presenting three cases which feature the association between hepatocytolysis, haemolysis and hypermagnesaemia. This clinical-biologic triad was highlighted with the workers who through the nature of their profession were exposing themselves periodically to vapours which contained copper sulphate neutralised with calcium hydroxide, a fungicide used for fruit trees. We are exclusively assessing the haematological perturbation. In this aetiological context, the generating mechanism for haemolysis is very probable biochemical, where hypercupraemia interferes with cellular antioxidant defence mechanisms. Hypothetically, the role of the redox homeostasis disorder in the intravascular destruction of erythrocytes is sustained, and particularly the coexistence of cell cytolysis in the medullary erythroid compartment, which can be assimilated with a possible ineffective erythropoiesis.Entities:
Keywords: Copper–calcium fungicide; haemolysis; hepatocytic cytolysis; hypercupraemia; hypermagnesaemia; ineffective erythropoiesis; oxidative stress
Mesh:
Substances:
Year: 2018 PMID: 29231762 PMCID: PMC7012014 DOI: 10.1080/14756366.2017.1409745
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051
Figure 1.Production of ROS – the role of superoxide dismutase (SODc) as an antioxidant agent.
The distribution and role of the isoenzymes/isoforms SOD at cellular level.
| Type and structure of the enzyme | Abbreviation | Localisation | Antioxidant action/neutralisation of ROS | |
|---|---|---|---|---|
| SOD copper-zinc (dimeric) | Cu–Zn (SOD1) | All types of cells | cytoplasm | By activating the endoplasmic reticulum or other cellular organelles, except for mitochondria |
| SOD-mangan (tetrameric) | MnSOD (SOD2) | mitochondria matrix | The process of synthesising macroergic compounds, through electron transport chains | |
| SOD–iron or nikel | ECSOD (SOD3) | All vascular endothelium and lungs | cell’s membrane | From the activity at cellular membrane level |
Results of laboratory tests for the three patients in the study.
| Reference values | Patients | |||||
|---|---|---|---|---|---|---|
| Parameters | Measure units | References (normal) | T.V (50 years old) | T.M. (29 years old) | T.G. (27 years old) | |
| Hb | g/dL | 13–16 | 12 | 12.3 | 12.8 | |
| ESR (men) | mm/1 h | <20 | 30 | 20 | 28 | |
| Blood glucose | mg/dL | 73–110 | 105 | 95 | 85 | |
| Bilirubin | ||||||
| total | mg/dL | <1.2 | 1.5 | 1.7 | 1.6 | |
| unconjugated | mg/dL | <0.8 | 1.1 | 1.3 | 1.2 | |
| TGP (ALT) | I.U./L | 5–21 | 70 | 40 | 45 | |
| TGO (AST) | I.U./L | 5–40 | 30 | 30 | 30 | |
| ALP | U/L | 30–126 | 140 | 135 | 125 | |
| creatinine | mg/%ml | <1.2 | 0.9 | 1 | 0.85 | |
| HDL cholesterol | mg/dL | ≥40 | 45 | 44 | 40 | |
| LDL cholesterol | mg/dL | <130 | 120 | 105 | 90 | |
| Triglycerides | mg/%ml | 30–135 | 280 | 200 | 170 | |
| CRP | mg/dL | <0.5 | 1 | 0.8 | 1.5 | |
| Free serum copper | µg %ml | 70–152 | 360 | 300 | 290 | |
| Serum ceruloplasmin | mg/%ml | 15–30 | 40 | 38 | 41 | |
| Electrolytes | ||||||
| Mg2+ | mg%dL | 1.6–2.55 | 5.4 | 5.9 | 5.7 | |
| critical level: ≥4,5 mg/dl | ||||||
| Ca2+ total | mg%dL | 8.4–10.3 | 8.5 | 7.7 | 7.9 | |
| Na+ | mmol/L | 135–145 | 137 | 135 | 138 | |
| K+ | mmol/L | 3.5–5 | 3.3 | 3.8 | 4 | |
| Urinary copper | mg/24 h | 10–60 | 90 | 80 | 85 | |
| Urinary urobilinogen | photometry | negative | positive | positive | positive | |
Figure 2.The role of pentoses shunt at the erythrocyte level in the synthesis of macro-active compounds and in the prevention of oxidation processes.
Figure 3.Involvement of cytochrome oxidase in the synthesis of macro-active compounds.